<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01341756</url>
  </required_header>
  <id_info>
    <org_study_id>B/09/134</org_study_id>
    <nct_id>NCT01341756</nct_id>
  </id_info>
  <brief_title>Palliative Radiotherapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II Trial</brief_title>
  <official_title>Palliative Radiotherapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University Hospital, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tan Tock Seng Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National University Hospital, Singapore</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this study is that a radiotherapy dose of 36Gy in 12 fractions, which
      equates to a BED of 48.6Gy, increases the response rates of symptom relief compared to
      historical controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The hypothesis of this study is that a radiotherapy dose of 36Gy in 12 fractions, which
      equates to a BED of 48.6Gy, increases the response rates of symptom relief compared to
      historical controls. (Tey et al.) With this dose fractionation is used for bleeding, there is
      an increase in response rates from 55%(historical) to 75%for pain, there is an increase in
      response rates from 25% (historical) to 45% for obstruction, there is an increase in response
      rates from 25% (historical) to 45%
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">July 2012</completion_date>
  <primary_completion_date type="Anticipated">July 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Response of bleeding to radiotherapy</measure>
    <time_frame>At the 12th fraction of radiotherapy and at one month post radiotherapy</time_frame>
    <description>Percentage of patients who do not require blood transfusion after radiotherapy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients who develop anorexia, nausea, vomiting as per common toxicity criteria v3.0</measure>
    <time_frame>within the first 14 days from start of radiotherapy</time_frame>
    <description>Toxicity</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">63</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Radiotherapy for gastric cancer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single arm study</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Palliative Radiotherapy</intervention_name>
    <description>Palliative Radiotherapy to a total dose of 36Gy in 12 fractions</description>
    <arm_group_label>Radiotherapy for gastric cancer</arm_group_label>
    <other_name>palliation, radiotherapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Biopsy proven adenocarcinoma of the stomach

          -  Treated with palliative intent

          -  At least one index symptom such as bleeding, obstruction or pain

          -  No prior abdominal radiotherapy

          -  Not on chemotherapy

        Exclusion Criteria:

          -  Patients treated with radical intent

          -  Previous abdominal radiotherapy

          -  Patients on chemotherapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeremy Tey, FRANZCR</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University Hospital, Singapore</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeremy Tey, FRANZCR</last_name>
    <phone>+65 67724869</phone>
    <email>jeremy_tey@nuhs.edu.sg</email>
  </overall_contact>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremy Tey, FRANZCR</last_name>
      <phone>+65 67724869</phone>
      <email>jeremy_Tey@nuhs.edu.sg</email>
    </contact>
    <investigator>
      <last_name>Jeremy Tey, FRANZCR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 18, 2011</study_first_submitted>
  <study_first_submitted_qc>April 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2011</study_first_posted>
  <last_update_submitted>May 6, 2011</last_update_submitted>
  <last_update_submitted_qc>May 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 9, 2011</last_update_posted>
  <responsible_party>
    <name_title>Jeremy Tey</name_title>
    <organization>National University Hospital</organization>
  </responsible_party>
  <keyword>Gastric Cancer</keyword>
  <keyword>Radiotherapy</keyword>
  <keyword>palliation</keyword>
  <keyword>bleeding</keyword>
  <keyword>pain</keyword>
  <keyword>obstruction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

